Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 120-08-1 Chemical Structure| 120-08-1

Structure of Scoparone
CAS No.: 120-08-1

Chemical Structure| 120-08-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Scoparone, a natural product isolated and purified from the herbs of Artemisia scoparia, with antifungal, antianginal, antioxidant, immunosuppression and vasorelaxation effects, protects against carbon tetrachloride-induced liver injury, is a very efficient inhibitor of ultraviolet radiation -induced lipid peroxidation and damage, and a phytoalexin associated with resistance of citrus to Phytophthora citrophthora.

Synonyms: Aesculetin dimethyl ether; 6,7-Dimethylesculetin; Escoparone

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Scoparone

CAS No. :120-08-1
Formula : C11H10O4
M.W : 206.19
SMILES Code : O=C1C=CC2=CC(OC)=C(OC)C=C2O1
Synonyms :
Aesculetin dimethyl ether; 6,7-Dimethylesculetin; Escoparone
MDL No. :MFCD00006871
InChI Key :GUAFOGOEJLSQBT-UHFFFAOYSA-N
Pubchem ID :8417

Safety of Scoparone

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301
Precautionary Statements:P301+P310
Class:6.1
UN#:2811
Packing Group:

Related Pathways of Scoparone

RTK

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
bone marrow-derived macrophages (BMDMs) 50 μM 2 h significantly inhibited caspase-1 cleavage, GSDMD-mediated pyroptosis, mature IL-1β secretion and the formation of ASC specks PMC10203299
mouse macrophage J774A.1 cells 50 μM 2 h significantly inhibited caspase-1 cleavage, GSDMD-mediated pyroptosis, mature IL-1β secretion and the formation of ASC specks PMC10203299
Huh7 cells 10 μM 24 h Scoparone significantly potentiated the activation of the BSEP promoter by CDCA, and this potentiation was enhanced in cells transfected with CYP1A2. PMC3221107
Primary human hepatocytes 10-100 μM 24 h Scoparone significantly increased CYP2B6 mRNA expression at 100 μM but had no significant effect on UGT1A1 or BSEP expression. PMC3221107
HepG2 cells 200 μM 24 h Inhibited STAT3 transcriptional activity, reduced cyclin D and M67 promoter activity PMC4351406
vascular smooth muscle cells (VSMCs) 500 μM 72 h Inhibited serum-stimulated VSMC proliferation, significantly reduced S phase cell accumulation, increased G0/G1 phase cell proportion, and decreased expression of cyclin D1, phosphorylated Rb, and survivin PMC4351406
AML12 cells 25 µM 24 h To observe the effect of scoparone on lipotoxic injured hepatocytes. Results showed that scoparone significantly improved PA-induced lipid deposition and apoptosis in hepatocytes. PMC9110978
HepG2 cells 25 µM 24 h To observe the effect of scoparone on lipotoxic injured hepatocytes. Results showed that scoparone significantly improved PA-induced lipid deposition and apoptosis in hepatocytes. PMC9110978

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J mice Bacterial enteritis and septic shock models Intraperitoneal injection and intragastric administration 50 mg/kg Single dose followed by observation after 12 hours for septic shock model; continuous administration for 9 days for enteritis model Scoparone significantly improved the survival rate of mice infected with bacteria, inhibited the secretion of IL-1β and TNF-α in serum, and reduced the infiltration of inflammatory cells in the lung, colon and liver PMC10203299
Mice Mice Intraperitoneal injection 10 mg/kg Twice, 12 hours apart Scoparone robustly activated the human BSEP promoter and significantly enhanced the expression of the endogenous mouse bsep gene. PMC3221107
C57BL/6J mice HFD-induced NASH model Oral 25, 50, and 100 mg/kg Once daily for 8 weeks To investigate the effect of scoparone on NASH mice. Results showed that scoparone significantly improved histopathological changes of liver tissues including mitochondrial number and morphology, lipid peroxide content, hepatosteatosis and inflammation, and decreased serum lipid and transaminase levels. PMC9110978
New Zealand rabbits Hyperlipidaemic diabetic rabbit model Subcutaneous injection 5 mg/kg Once daily for 6 weeks Scoparone significantly reduced plasma lipid and lipoprotein cholesterol levels and protected against pathological alterations in vascular morphology and reactivity in hyperlipidaemic diabetic rabbits. PMC2175843
Mice Maximal electroshock-induced (MES) tonic-clonic seizure model Intraperitoneal injection 199.8 mg/kg to 320.1 mg/kg 15, 30, 60 and 120 minutes To evaluate the anticonvulsant effects of Scoparone in the mouse maximal electroshock model PMC9867083

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.85mL

0.97mL

0.48mL

24.25mL

4.85mL

2.42mL

48.50mL

9.70mL

4.85mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories